⌘K

Login Start Free

Home/Filings/4/0000899243-22-036181

4//SEC Filing

Hamdy Ahmed MD 4

Accession 0000899243-22-036181

CIK 0001796129other

View on SEC.gov Company Profile

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 4:06 PM ET

Size

5.5 KB

Accession

0000899243-22-036181

Insider Transaction Report

Form 4

Period: 2022-11-15

Vincerx Pharma, Inc.VINC

DirectorPresident and CEO10% Owner

Transactions

Award
Stock Option (right to buy)
2022-11-15+60,000→ 60,000 total
Exercise: $0.82Exp: 2032-11-14→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]Option vests in twenty-four equal monthly installments starting from November 15, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vincerx Pharma, Inc.

CIK 0001796129

Entity typeother

Related Parties

1

filerCIK 0001458506

Filing Metadata

Form type: 4
Filed: Nov 16, 7:00 PM ET
Accepted: Nov 17, 4:06 PM ET
Size: 5.5 KB

View on SEC.gov